SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000895345-24-000014
Filing Date
2024-01-23
Accepted
2024-01-23 15:29:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 ff2943026_13g-evaxion.htm SC 13G 129703
2 ff2943026_ex991-evaxion.htm EX-99.1 7749
  Complete submission text file 0000895345-24-000014.txt   139258
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Subject) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94294 | Film No.: 24552312
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)